In previous studies we were able to show that bladder carcinoma cell l
ines are in vitro resistant against natural killer (NK) cell activity.
After stimulation of the mononuclear effector-cells with interlaukin-
2 (IL-2) or BCG an efficient cytotoxicity against bladder carcinoma ce
ll lines could be demonstrated. The aim of the present study was to sh
ow, if also carcinoma cells of primary bladder tumors are NK-resistant
or if this is only an in vitro phenomenon of the tumor cell lines. We
were able to show in a L-[H-3]-methionine-cytotoxicity-assay that eve
n short time cultured cells of primary bladder tumors are resistant ag
ainst autologous and allogenic NK-cells, but are also sensitive agains
t lymphokine-activated killer (LAK) cells and BCG-actiated killer (BAK
) cells. Furthermore we found, that NK-cells of healthy donors and of
our patients did not differ in their cytotoxic potential against cells
of primary bladder tumors and bladder carcinoma cell lines. We conclu
de that these data show the relevance of our in vitro findings for the
in vivo situation and prove the importance of stimulation for the kil
ling of tumor cells in vivo.